Quick Links

ALL ALS ASSESS Study

ALL ALS ASSESS Study

The ASSESS study combines a longitudinal natural history study and biomarker collection for ALS. It aims to make ALS research accessible to everyone, including those who cannot visit academic medical centers, through new technology that allows remote participation. We are looking for people currently living with ALS, individuals who do not have ALS, are not known ALS gene carriers, or at risk of carrying an ALS causative gene to help researchers gain a deeper understanding of ALS and improve future clinical trials.

Participation will consist of in-person and/or remote visits where clinical data such as blood samples and cerebrospinal fluid (optional) will be collected. Participants will also complete speech tasks and questionnaires via our online portal.

Learn more about the ALL ALS study here: https://www.all-als.org/

Participant Eligibility

Who can participate in the ASSESS study?

Individuals currently living with ALS

Control participants including:
– Individuals without ALS or known ALS gene mutations
– Spouses or family members of ALS patients who tested negative for ALS gene mutations
– General population or others encountered at ALS sites
– Must not be at risk of carrying a causative ALS gene mutation

Contact

Lila Brisk
(206) 543-0454

Additional Study Details

Full Study Title
ASSESS ALL ALS study

Study ID: 2024P001132
Start Date: 08/27/2024
End Date: 12/31/2026

Investigator(s)
Michael Weiss, MD (Principal Investigator)
Jane Distad, MD

Accepts Healthy Volunteers?
Yes

Study Site(s)

University of Washington Medical Center – Montlake

1959 NE Pacific St, Seattle, WA 98195
Seattle, Washington 98195



Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.

SITE PARTNERS
uw-footer